Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Hao

Showing results (371-380 of 850) with videos related to

Pageof 85
Sort By:
Disease Markers|June 14, 2019
NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal Cancer Cells through Downregulating CCND1 and pRb1-ser807/811Lihua Zhang, Dong-Li Hu, Baiyou Tang, et al.
International Journal of Molecular Sciences|December 10, 2021
Correction: Shao et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 350Ying-Ying Shao, Tao-Lan Zhang, Lan-Xiang Wu, et al.
Endocrine|September 23, 2018
MIR4532 gene variant rs60432575 influences the expression of KCNJ11 and the sulfonylureas-stimulated insulin secretionZhang-Ren Chen, Fa-Zhong He, Mou-Ze Liu, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2018
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitroJia-Feng Huang, Chun-Jie Wen, Guo-Zhi Zhao, et al.
Die Pharmazie|September 17, 2015
Pharmacogenomics research: a potential strategy for drug developmentJia-Gen Wen, Lin Wu, Xin-Xiang Pu, et al.
Journal of the American Chemical Society|July 13, 2016
Visible-Light-Driven Selective Photocatalytic Hydrogenation of Cinnamaldehyde over Au/SiC CatalystsCai-Hong Hao, Xiao-Ning Guo, Yung-Tin Pan, et al.
Die Pharmazie|November 26, 2015
MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammationChong-Zhen Qin, Xiao-Ya Lou, Qiao-Li Lv, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2017
Metabolic analysis of Panax notoginseng saponins with gut microbiota-mediated biotransformation by HPLC-DAD-Q-TOF-MS/MSMan-Yun Chen, Li Shao, Wei Zhang, et al.
Acta Pharmacologica Sinica|May 3, 2014
Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitroQiang Qu, Jian Qu, Lu Han, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
Analysis of Lifestyle and Genetic Risk Factors in Urban Women in China Who Had Malignant or Suspected Malignant Breast Nodules Identified via Breast Cancer ScreeningJun-Luan Mo, Lin Lei, Xi Li, et al.
Pageof 85

Showing results (371-380 of 850) with videos related to

Sort By:
Pageof 85
Disease Markers|June 14, 2019
NFE2L3 Inhibition Induces Cell Cycle Arrest at the G0/G1 Phase in Colorectal Cancer Cells through Downregulating CCND1 and pRb1-ser807/811Lihua Zhang, Dong-Li Hu, Baiyou Tang, et al.
International Journal of Molecular Sciences|December 10, 2021
Correction: Shao et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 350Ying-Ying Shao, Tao-Lan Zhang, Lan-Xiang Wu, et al.
Endocrine|September 23, 2018
MIR4532 gene variant rs60432575 influences the expression of KCNJ11 and the sulfonylureas-stimulated insulin secretionZhang-Ren Chen, Fa-Zhong He, Mou-Ze Liu, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2018
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitroJia-Feng Huang, Chun-Jie Wen, Guo-Zhi Zhao, et al.
Die Pharmazie|September 17, 2015
Pharmacogenomics research: a potential strategy for drug developmentJia-Gen Wen, Lin Wu, Xin-Xiang Pu, et al.
Journal of the American Chemical Society|July 13, 2016
Visible-Light-Driven Selective Photocatalytic Hydrogenation of Cinnamaldehyde over Au/SiC CatalystsCai-Hong Hao, Xiao-Ning Guo, Yung-Tin Pan, et al.
Die Pharmazie|November 26, 2015
MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammationChong-Zhen Qin, Xiao-Ya Lou, Qiao-Li Lv, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2017
Metabolic analysis of Panax notoginseng saponins with gut microbiota-mediated biotransformation by HPLC-DAD-Q-TOF-MS/MSMan-Yun Chen, Li Shao, Wei Zhang, et al.
Acta Pharmacologica Sinica|May 3, 2014
Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitroQiang Qu, Jian Qu, Lu Han, et al.
Breast Care (Basel, Switzerland)|May 7, 2025
Analysis of Lifestyle and Genetic Risk Factors in Urban Women in China Who Had Malignant or Suspected Malignant Breast Nodules Identified via Breast Cancer ScreeningJun-Luan Mo, Lin Lei, Xi Li, et al.
Pageof 85